MedTrace Logo

Inflammation and Organ Impact During Hepatic Surgery

NCT03878615 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2025-04-27

No results posted yet for this study

Summary

Monitoring of inflammatory substances (such as interleukins, CRP, albumine), and markers of organ dysfunction (such as creatinine, proenkephaline, amylase, troponine, IFABP and lactate) during elective liver resection. The study also includes monitoring of hemodynamic parameters, blood loss and postoperative complications. Results are to be used för power calculation for future trials.

Conditions

  • Hepatic Surgery

Interventions

PROCEDURE

elective surgery, according to deprtement routine

none, descriptive study

Sponsors & Collaborators

  • Sahlgrenska University Hospital

    lead OTHER

Principal Investigators

  • Sven-Erik Ricksten, MD, PhD, professor · Sahlgrenska University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-10
Primary Completion
2019-04-02
Completion
2019-04-02

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03878615 on ClinicalTrials.gov